Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 4 1Phase 1 1

Status

Completed 232Terminated 60Recruiting 46Active not recruiting 27Withdrawn 19Unknown 15Not yet recruiting 11Suspended 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Recurrence 3Neoplasms 3Stomach Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Glioblastoma 2Breast Neoplasms 2Advanced Solid Tumor 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Rhabdomyosarcoma 1Prostatic Neoplasms, Castration-Resistant 1Nevus 1Neurofibromatosis 1 1Neurofibroma 1Nervous System Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lymphatic Metastasis 1Head and Neck Neoplasms 1HER2-positive Advanced Solid Tumor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Enrolling by invitation × Brain Neoplasms × Clear all
NCT03170141 2026-04-24

Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme

Shenzhen Geno-Immune Medical Institute

Phase 1 Enrolling by invitation
30 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡